Business Development

SciVida knows that business development and licensing deals often move rapidly and require agility, as making well-informed decisions under tight time constraints can be challenging. SciVida assists emerging and established companies alike in assessing a market, evaluating potential for a product, and informing decisions on valuation and go/no-go.

Key Market Dynamics

Increasing competition for licensing deals

Rising number of midsize companies pursuing accelerated growth

Increasing reliance of big pharma and big biotech on licensing for growth and innovation

Solutions

SciVida can assist life sciences organizations in tackling key business development questions through several solutions:

HOW DO WE GROW OUR PORTFOLIO
THROUGH EXTERNAL INNOVATION? 01

Corporate growth strategy
Portfolio strategy
Business development and licensing strategy

How We’ve Helped Our Clients

Like precision medicine where treatment decisions are personalized for each individual patient, we tailor our consulting solutions to each client’s unique set of circumstances. No two situations are exactly the same, so every engagement is different. The case studies below illustrate how we have supported clients with business development needs.

Case Study

In-Licensing Due Diligence

Case Study

BD Partner/Investor Presentation

Client Satisfaction Is Our Top Metric

SciVida thrives on feedback! We welcome input from clients in any forum throughout the project, and we also provide a formal opportunity to thoroughly evaluate our performance at the end of each engagement to ensure we stay focused on customer needs and continuously improve quality.

100% of clients would endorse SciVida to colleagues and business acquaintances
100% of clients report SciVida demonstrated a good understanding of their business
100% of clients would work with SciVida again

9.9 Out of 10

Average customer satisfaction score

You guys are light years ahead of other firms we are working with.
—Vice President, Pricing and Market Access, Midsize Global Biopharma

I say this as someone who has 30 years of experience in the industry and who has worked with so many consultancies, including a lot of big-box firms. You guys did extremely well. You clearly know what you are doing.
—Senior Director, Global Market Access, Midsize Biopharma

We were most pleased with the direct involvement of senior partners, great attention to detail, proactive communication, and engagement with multiple client stakeholders.
—Senior Director, Marketing and New Product Planning, Small Biotech

I was delighted to see the robustness and flexibility of the modeling tools. Both exceeded my expectations as enduring deliverables.
—Head of Market Access and Reimbursement, Midsize Global Pharma

In my 12 years in marketing, this is the best work I’ve ever seen.
—Director of Marketing, Large Global Pharma

This impressive deliverable is what we need to move the organization forward. I’m appreciative of this great start to our partnership and looking forward to solving many more challenges together!
—Senior Director, New Product Commercial Strategy, Midsize Biotech

SciVida was incredibly organized and made a very difficult and complex project easy to digest—we knew what was needed and what was going to happen every step of the way.
—Director, Patient Access Strategy, Midsize Biopharma

It was truly a pleasure to work with SciVida. The integrity and thoughtfulness of the team and the ease of communication with them made our experience particularly good, on top of the high quality of the work product.
—President and CEO, Emerging Biotech

My colleague hyped your firm, and you lived up to the hype. Really nice work, SciVida team.
—VP, Marketing and Sales, Emerging Biopharma